AI-Platform to Tackle Cancer on a Genetic Level

November 22, 2024

We’re building an AI-powered platform to tackle cancer on a genetic level.

What does the platform do?

1. Performs analyse of a person’s genetic code.

2. Identifies mutations in the genetic code.

3. Explores ways to suppress these gene mutations.

The process is powered by AI. Our data is based on renowned publications and is updated daily.

Through this process, we can understand which mutations lead to specific diseases and, accordingly, identify which medications or off-label drugs could help suppress the mutation, enabling the person to recover.

This platform, based on our profound expertise in the field of oncology backed up by AI, is an innovative way to address the problem at its root.

New ISO Certification

🏆 We’re proud to share that Vita Motus AG has once again been awarded the ISO

Exosomes Digest (4/4 August 2025)

We have collected the most exciting new research in the field of genetics and cellular reserach.

Thank you ISEV 2025!

We attended ISEV 2025, one of the world’s leading conferences focused on extracellular vesicles. It was